I did not realise that sales outside US were two thirds US sales. Still significant. Analyst007 states that we a re a US company. Not entirely as we may progress greatly in China with their specific open or closed angle glaucoma . The iTrackadvance will gain traction there with best in class and ease of use. If a big institutional investor sold down at 28c in order to reenter at say a 10 percent discount this would not look good. Would look like inside trading. I hope it’s not the case and I have no evidence to support it. I hope this coming week reports that we will be cash flow positive in 3 months and we will have a 2RT concluded by then. Hope again springs eternal
Nova Eye Medical (EYE) Discussion, page-2321
-
- There are more pages in this discussion • 761 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.5¢ | $64.12K | 295.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 378358 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 20650 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| EYE (ASX) Chart |